174 related articles for article (PubMed ID: 31803318)
1. Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study.
Al-Lawama M; Badran E; Elrimawi A; Bani Mustafa A; Alkhatib H
J Clin Med Res; 2019 Nov; 11(11):760-763. PubMed ID: 31803318
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
3. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review.
Zheng Y; Almeyda-Alejo Y; Tumin D; Redpath NSJ; Guillen-Hernandez J
J Neonatal Perinatal Med; 2024; 17(1):153-158. PubMed ID: 38143377
[TBL] [Abstract][Full Text] [Related]
4. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
Li ZH; Wang J; Chen C
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.
Okulu E; Erdeve O; Kilic I; Olukman O; Calkavur S; Buyukkale G; Cetinkaya M; Ulubas D; Demirel N; Hanta D; Ertugrul S; Gultekin ND; Tuncer O; Demir N; Bilgin L; Narli N; Yildiz D; Terek D; Koroglu OA; Seren C; Ozyazici E; Ozdemir R; Turgut H; Narter F; Akin Y; Ozyazici A; Zenciroglu A; Asker HS; Gokmen Z; Salihli M; Bulbul A; Zubarioglu U; Atasay B; Koc E;
Front Pediatr; 2022; 10():864609. PubMed ID: 35573949
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
7. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
[TBL] [Abstract][Full Text] [Related]
8. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
[TBL] [Abstract][Full Text] [Related]
9. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
12. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?
Beken S; Hirfanoglu I; Turkyilmaz C; Altuntas N; Unal S; Turan O; Onal E; Ergenekon E; Koc E; Atalay Y
Indian J Hematol Blood Transfus; 2014 Mar; 30(1):12-5. PubMed ID: 24554813
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn.
Jalali SZ; Mahdipour S; Asgarzad R; Saadat F
Hematol Transfus Cell Ther; 2024 Apr; ():. PubMed ID: 38719722
[TBL] [Abstract][Full Text] [Related]
16. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
Kappas A; Drummond GS; Munson DP; Marshall JR
Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
Alcock GS; Liley H
Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
[TBL] [Abstract][Full Text] [Related]
18. A Description of IVIG Use in Term Neonates with ABO Incompatibility.
Daunov M; Schlosser A; Malay S; Adams J; Clark R; Ferrerosa L; Pateva I
Am J Perinatol; 2024 Mar; ():. PubMed ID: 38286423
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study.
Pan J; Zhan C; Yuan T; Chen X; Ni Y; Shen Y; Chen W; Wu T; Yu H
J Perinatol; 2021 Jun; 41(6):1397-1402. PubMed ID: 33589732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
